Two factors compound: drug exposure scales with body weight (lighter body = more drug per pound), and physiological response varies by metabolic and cardiovascular phenotype
The formulation brings together two peptides with complementary mechanistic profiles within the growthhormone (somatotropic) axis: CJC1295, a growthhormonereleasing hormone (GHRH) analogue, for GHRHreceptor signalling studies
SCFAs involved in the physiological activities of the body mainly through three G protein-coupled receptors, GPR41 (FFAR3), GPR43 (FFAR2), and GPR109A, which are variably expressed in different cells, and interfered in the occurrence and development of NAFLD by regulating glucose and lipid metabolism, restoring the intestinal barrier, and improving oxidative stress (Ikeda et al., 2022)
Maintenance dosing schedules are less often than the first doses, usually monthly